Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon  

作者: J-L Yang

DOI: 10.1136/GUT.53.1.123

关键词: Growth factor receptorA431 cellsInternal medicineEndocrinologyCell growthEpidermal growth factorIntracellularCancer researchCancer cellEpidermal growth factor receptorBiologySignal transductionGastroenterology

摘要: Background and aim: The biology of growth factor receptor expression has implications for specific cancer therapy. In this study, we examined: (a) regulation epidermal (EGFR) in a panel 10 human colon cell lines using interferon α (IFN-α); (b) ability IFN-α to inhibit proliferation; (c) sensitivity pretreated cells EGF. Methods: Cell proliferation was measured both by crystal violet colorimetric clonogenic assays. surface, intracellular, and/or total protein EGFR assessed indirect immunofluorescence flow cytometry fluorescein isothiocyanate (FITC)-EGF binding internalisation cytometric assay. Results: treatment upregulated surface seven within 16 hours, reaching peak 48–96 hours; accompanied transient elevation intracellular marked inhibition. treated were still sensitive EGF proliferative stimulation. Conclusions: Our results indicate that cytostatic concentrations can enhance proportion cells. antiproliferative action could not block the signal transduction EGF-EGFR pathway. This may have clinical improving based on targeting EGFR.

参考文章(38)
Michael David, Lily Wong, Richard Flavell, Stewart A. Thompson, Alan Wells, Andrew C. Larner, Gibbes R. Johnson, STAT Activation by Epidermal Growth Factor (EGF) and Amphiregulin REQUIREMENT FOR THE EGF RECEPTOR KINASE BUT NOT FOR TYROSINE PHOSPHORYLATION SITES OR JAK1 Journal of Biological Chemistry. ,vol. 271, pp. 9185- 9188 ,(1996) , 10.1074/JBC.271.16.9185
G Carpenter, S Cohen, Epidermal growth factor. Journal of Biological Chemistry. ,vol. 265, pp. 7709- 7712 ,(1972) , 10.1016/S0021-9258(19)38983-5
S Paik, R Hazan, E R Fisher, R E Sass, B Fisher, C Redmond, J Schlessinger, M E Lippman, C R King, Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer. Journal of Clinical Oncology. ,vol. 8, pp. 103- 112 ,(1990) , 10.1200/JCO.1990.8.1.103
Zhen Fan, Jia Ling Chou, Yang Lu, Barbara Y. Shang, John Mendelsohn, Reciprocal changes in p27(Kip1) and p21(Cip1) in growth inhibition mediated by blockade or overstimulation of epidermal growth factor receptors. Clinical Cancer Research. ,vol. 3, pp. 1943- 1948 ,(1997)
M. Caraglia, A. Pinto, P. Correale, V. Zagonel, G. Genua, A. Leardi, S. Pepe, A.R. Bianco, P. Tagliaferri, 5-Aza-2′-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells Annals of Oncology. ,vol. 5, pp. 269- 276 ,(1994) , 10.1093/OXFORDJOURNALS.ANNONC.A058806
Neil S. Sadick, Carlos Urmacher, Estrogen and Progesterone Receptors Dermatologic Surgery. ,vol. 25, pp. 539- 543 ,(1999) , 10.1046/J.1524-4725.1999.99026.X
Jennifer Rubin Grandis, Mona F. Melhem, William E. Gooding, Roger Day, Valerie A. Holst, Marilyn M. Wagener, Stephanie D. Drenning, David J. Tweardy, Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival Journal of the National Cancer Institute. ,vol. 90, pp. 824- 832 ,(1998) , 10.1093/JNCI/90.11.824
Michele Caraglia, Pierosandro Tagliaferri, Pierpaolo Correale, Geppino Genua, Antonio Pinto, Silvana Del Vecchio, Giuseppe Esposito, Angelo Raffaele Bianco, Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in vitro targeting of human tumour cells with anti-(growth factor receptor) mAb. Cancer Immunology, Immunotherapy. ,vol. 37, pp. 150- 156 ,(1993) , 10.1007/BF01525428
Kimberley Pryor, Phillip Stricker, Pamela Russell, David Golovsky, Ronald Penny, Antiproliferative effects of bacillus Calmette-Guérin and interferon α2b on human bladder cancer cells in vitro Cancer Immunology, Immunotherapy. ,vol. 41, pp. 309- 316 ,(1995) , 10.1007/BF01517219